Disparities Seen in Continuous Glucose Monitor Rx by Language Preference

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on June 27, 2025.

via HealthDay

FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access to CGM prescriptions for adult patients with non-English language preference (NELP), according to a study published online June 17 in JAMA Network Open.

Jorge A. Rodriguez, M.D., from Brigham and Women's Hospital in Boston, and colleagues compared CGM prescriptions between patients with NELP and patients with English language preference (ELP) in a cohort consisting of adults with T2D receiving primary care or endocrinology care from Jan. 1, 2022 to Dec. 31, 2023. Language preference was dichotomized as NELP or ELP according to the preferred language field on the electronic health record. The primary outcome was CGM prescription.

The study included 69,269 patients with T2D; 12.1 percent of the cohort consisted of patients with NELP. The researchers found that 12.2 percent of patients had at least one CGM prescription. Compared to patients with ELP, in unadjusted analyses, a lower proportion of patients with NELP had a CGM prescription (7.4 versus 12.7 percent). Furthermore, patients with NELP were significantly less likely to have a CGM prescription in adjusted analyses (adjusted odds ratio [aOR], 0.58). In sensitivity analyses of patients with uncontrolled diabetes (hemoglobin A1c >9 percent) and patients using insulin, this difference persisted (aORs, 0.59 and 0.70, respectively).

"Our study highlights the specific role of language preference in CGM prescribing patterns," the authors write.

Several authors disclosed ties to industry; one author holds a related patent.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-28 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords